{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T10:25:26Z","timestamp":1794997526372,"version":"4.9.1"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Continuum"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1212\/01.con.0000455883.91426.12","type":"journal-article","created":{"date-parts":[[2014,10,10]],"date-time":"2014-10-10T22:07:53Z","timestamp":1412978873000},"page":"1241-1260","source":"Crossref","is-referenced-by-count":8,"title":["Acquired Immune Demyelinating Neuropathies"],"prefix":"10.1212","volume":"20","author":[{"given":"Mazen M.","family":"Dimachkie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Saperstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_1_6_2","unstructured":"Centers for Disease Control and Prevention. Seasonal Influenza Vaccine Safety: A Summary for Clinicians. www.cdc.gov\/flu\/professionals\/vaccination\/vaccine_safety.htm. Accessed February 16 2014."},{"key":"e_1_3_1_7_2","unstructured":"Ropper AH Wijdicks EF Truax BT. Guillain-Barr\u00e9 syndrome contemporary neurology series 34. Clinical features of the typical syndrome. Philadelphia: FA Davis; 1991."},{"key":"e_1_3_1_8_2","doi-asserted-by":"crossref","unstructured":"Asbury AK Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barr\u00e9 syndrome. Ann Neurol 1990; 27 (suppl S21\u201324).","DOI":"10.1002\/ana.410270707"},{"key":"e_1_3_1_13_2","doi-asserted-by":"crossref","unstructured":"Hughes RA Wijdicks EF Barohn R et al.; Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: immunotherapy for Guillain-Barr\u00e9 syndrome: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2003; 61 (6): 736\u2013740.","DOI":"10.1212\/WNL.61.6.736"},{"key":"e_1_3_1_18_2","unstructured":"Erasmus MC\/IGOS. IGOS GBS Prognosis Tool. http:\/\/www.gbstools.org\/prognosis-tool. Accessed June 25 2014."},{"key":"e_1_3_1_25_2","doi-asserted-by":"crossref","unstructured":"Van den Bergh PY Hadden RD Bouche P et al.; European Federation of Neurological Societies; Peripheral Nerve Society. European Federation of Neurological Societies\/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society\u2014first revision. Eur J Neurol 2010; 17 (3): 356\u2013363.","DOI":"10.1111\/j.1468-1331.2009.02930.x"},{"key":"e_1_3_1_36_2","doi-asserted-by":"crossref","unstructured":"Hughes RA Donofrio P Bril V et al.; ICE Study Group. Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial. Lancet Neurol 2008; 7 (2): 136\u2013144.","DOI":"10.1016\/S1474-4422(07)70329-0"},{"key":"e_1_3_1_37_2","doi-asserted-by":"crossref","unstructured":"Nobile-Orazio E Cocito D Jann S et al.; IMC Trial Group. Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial. Lancet Neurol 2012; 11 (6): 493\u2013502.","DOI":"10.1016\/S1474-4422(12)70093-5"},{"key":"e_1_3_1_42_2","doi-asserted-by":"crossref","unstructured":"Markvardsen LH Debost JC Harbo T et al.; Danish CIDP and MMN Study Group. Subcutaneous immunoglobulin in responders to intravenous therapy with chronic inflammatory demyelinating polyradiculoneuropathy. Eur J Neurol 2013; 20 (5): 836\u2013842.","DOI":"10.1111\/ene.12080"},{"key":"e_1_3_1_43_2","doi-asserted-by":"crossref","unstructured":"Cocito D Paolasso I Antonini G et al.; Italian Network for CIDP Register. A nationwide retrospective analysis on the effect of immune therapies in patients with chronic inflammatory demyelinating polyradiculoneuropathy. Eur J Neurol 2010; 17 (2): 289\u2013294.","DOI":"10.1111\/j.1468-1331.2009.02802.x"},{"key":"e_1_3_1_44_2","doi-asserted-by":"crossref","unstructured":"Cocito D Grimaldi S Paolasso I et al.; Italian Network for CIDP Register. Immunosuppressive treatment in refractory chronic inflammatory demyelinating polyradiculoneuropathy. A nationwide retrospective analysis. Eur J Neurol 2011; 18 (12): 1417\u20131421.","DOI":"10.1111\/j.1468-1331.2011.03495.x"},{"key":"e_1_3_1_49_2","doi-asserted-by":"crossref","unstructured":"Van den Berg-Vos RM Van den Berg LH Franssen H et al. Multifocal inflammatory demyelinating neuropathy: a distinct clinical entity? Neurology 2000; 54 (1): 26\u201332.","DOI":"10.1212\/WNL.54.1.26"}],"container-title":["Continuum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1212\/01.CON.0000455883.91426.12","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T14:09:03Z","timestamp":1752156543000},"score":1,"resource":{"primary":{"URL":"https:\/\/continuum.aan.com\/doi\/10.1212\/01.CON.0000455883.91426.12"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":12,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["10.1212\/01.CON.0000455883.91426.12"],"URL":"https:\/\/doi.org\/10.1212\/01.con.0000455883.91426.12","relation":{},"ISSN":["1080-2371","1538-6899"],"issn-type":[{"value":"1080-2371","type":"print"},{"value":"1538-6899","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10]]}}}